Crystal structures of 5-Bromo-2-hydroxybenzaldehyde, 2-hydroxy-3- methoxybenzaldehyde, and 2-hydroxynaphthalene-1-carbaldehyde 4-(2-pyridyl) thiosemicarbazones
Закрыть
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
60 0
SM ISO690:2012
CHUMAKOV, Yurii, PETRENKO, Peter A., CODIŢĂ, Tatiana, TSAPKOV, Victor I., POIRIER, Donald, GULYA, Aurelian. Crystal structures of 5-Bromo-2-hydroxybenzaldehyde, 2-hydroxy-3- methoxybenzaldehyde, and 2-hydroxynaphthalene-1-carbaldehyde 4-(2-pyridyl) thiosemicarbazones. In: Crystallography Reports, 2014, vol. 59, pp. 207-212. ISSN 1063-7745. DOI: https://doi.org/10.1134/S1063774514020072
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Crystallography Reports
Volumul 59 / 2014 / ISSN 1063-7745 /ISSNe 1562-689X

Crystal structures of 5-Bromo-2-hydroxybenzaldehyde, 2-hydroxy-3- methoxybenzaldehyde, and 2-hydroxynaphthalene-1-carbaldehyde 4-(2-pyridyl) thiosemicarbazones

DOI:https://doi.org/10.1134/S1063774514020072

Pag. 207-212

Chumakov Yurii1, Petrenko Peter A.1, Codiţă Tatiana2, Tsapkov Victor I.2, Poirier Donald3, Gulya Aurelian2
 
1 Institute of Applied Physics, Academy of Sciences of Moldova,
2 Moldova State University,
3 Universitatea Laval
 
 
Disponibil în IBN: 20 ianuarie 2024


Rezumat

5-Bromo-2-hydroxybenzaldehyde, 2-hydroxy-3-methoxybenzaldehyde, and 2-hydroxynaphthalene-1-carbaldehyde 4-(2-pyridyl) thiosemicarbazones (I-III, respectively) were synthesized and their crystal structures were determined by X-ray diffraction. All these molecules are almost planar. The presence of bulky substituents at the terminal nitrogen atoms of these molecules does not lead to changes in the conformation of the thiosemicarbazide moiety. Depending on the nature of substituents in the phenol rings, the crystals are composed of either centrosymmetric dimers (I) or infinite chains (II and III). In the concentration range of 10-5-10-7 mol/L, thiosemicarbazones I-III selectively inhibit the growth of human myeloid leukemia HL60 cells. 

Cuvinte-cheie
Bulky substituents, Centrosymmetric dimers, Concentration ranges, Human myeloid leukemia, Methoxybenzaldehyde, Terminal-nitrogen, Thiosemicarbazides, thiosemicarbazone